InvestSMART

Cogstate Limited (ASX: CGS) - Announcements

Current share price for CGS : $3.090 0.02 (0.65%)+

ASX company news and announcements for Cogstate Limited (CGS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cogstate Limited (CGS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cogstate Limited (CGS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cogstate Limited (CGS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$531 Appendix 4E and Preliminary Final Report 22 Aug 2017 8:23AM $1.050 $3.090 risen by 194.29%
$531 Notification of Full Year Results &Investor Conference Call 15 Aug 2017 9:01AM $1.055 $3.090 risen by 192.89%
$531 Cogstate cleared by FDA to start marketing Cognigram in U.S. 27 Jul 2017 9:33AM $1.050 $3.090 risen by 194.29%
$531 Amendment to request for Trading Halt 26 Jul 2017 10:02AM $1.050 $3.090 risen by 194.29%
$531 Trading Halt 26 Jul 2017 9:04AM $1.050 $3.090 risen by 194.29%
$531 FY17 Earnings Update 11 Jul 2017 8:38AM $1.125 $3.090 risen by 174.67%
$531 Business Update and Appendix 4C 11 Jul 2017 8:35AM $1.125 $3.090 risen by 174.67%
$531 Appendix 3B 30 Jun 2017 11:35AM $1.150 $3.090 risen by 168.70%
$531 Appendix 3B 8 Jun 2017 9:52AM $1.140 $3.090 risen by 171.05%
$531 Change of Director's Interest Notice 5 Jun 2017 10:18AM $1.110 $3.090 risen by 178.38%
$531 Change of Director's Interest Notice 1 Jun 2017 10:55AM $1.020 $3.090 risen by 202.94%
$531 Appendix 3B 30 May 2017 3:44PM $0.950 $3.090 risen by 225.26%
$531 Cogstate selected as preferred provider for Lilly 18 May 2017 8:44AM $0.790 $3.090 risen by 291.14%
$531 Business Update and Appendix 4C 28 Apr 2017 9:52AM $0.935 $3.090 risen by 230.48%
$531 Appendix 3B 10 Apr 2017 10:06AM $0.925 $3.090 risen by 234.05%
$531 S&P DJ Indices Announces March Quarterly Rebalance 10 Mar 2017 8:19AM $1.035 $3.090 risen by 198.55%
$531 Change in substantial holding 7 Mar 2017 8:30PM $1.030 $3.090 risen by 200%
$531 Appendix 4D and Half-Year Financial Report 23 Feb 2017 8:53AM $1.140 $3.090 risen by 171.05%
$531 Notification of Half Year Results & Investor Conference Call 21 Feb 2017 1:15PM $1.100 $3.090 risen by 180.91%
$531 Initial Director's Interest Notice 30 Jan 2017 4:11PM $1.300 $3.090 risen by 137.69%
$531 Investor Presentation 30 Jan 2017 9:04AM $1.300 $3.090 risen by 137.69%
$531 Director Appointment/Resignation 27 Jan 2017 8:22AM $1.240 $3.090 risen by 149.19%
$531 Business Update and Appendix 4C 23 Jan 2017 9:21AM $1.340 $3.090 risen by 130.60%
$531 Initial Director's Interest Notice 20 Jan 2017 9:40AM $1.280 $3.090 risen by 141.41%
$531 Director Appointment/Resignation 20 Jan 2017 8:27AM $1.280 $3.090 risen by 141.41%

701 - 725 of 1000 results

Page 29 of 40

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.